A CML Advocate's Perspective on News from ASH 2012
Description: Greg Stephens, executive director of the National CML Society, a Patient Power partner, reports from the ASH meeting on his excitement about the expanding range of approved therapies for CML. He is very pleased there are new options for people living with "mutated disease." However, he advises patients to stick with therapies that may be working for them rather than simply changing because something is new. Greg, the son of a woman who died from CML, is thrilled with the progress, but he reminds patients that the disease remains serious and patients must work with their doctors to ensure their treatment is right for their personal situation.
Shared By : patientpower
Posted on : 12/21/12
Added : 4 years ago